1.5mg semaglutide GLP-1SG – 5mg – Prime Lab Peptides 💙Starting a GLP-1 medication can

Never stop taking any medications without discussing them with a medical professional first

Regular communication with healthcare providers enables timely interventions and dose modifications whenever necessary, particularly if serious side effects emerge

Glucagon-like peptide 1 (GLP-1) receptor agonist, treatment for type 2 diabetes

(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects

These findings suggest that dose optimization may significantly enhance treatment outcomes across the GLP-1 class ^1